Catalent Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
1312 / 1328
Position in country
14081 / 14179
Return on Assets, %
-12.5
-2.7
Net income margin, %
-20.2
2.8
EBITDA margin, %
2.1
10.8
Debt to Equity, %
135.7
19.2
Intangible assets and goodwill, %
32.6
3.6
Revenue CAGR 3Y, %
11.2
8.5
Total Equity change 1Y, %
-25
0
Revenue Y, % chg
-13.4
0.5
P/BV
2.7
1.5
P/S
2.4
2.3
EV/S
3.6
2.4
EV/EBITDA
49.3
7.4
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
12.7
51.3
Forward P/E
44.3
15.6
Expected dividend per share
0
0
Competitors
Ranks
-
Royalty Pharma PLC
00%
-
Zoetis Inc
00%
-
Eli Lilly and Co
00%
-
Bristol-Myers Squibb Co
00%
-
Organon & Co
00%
-
Johnson & Johnson
00%
-
Viatris Inc
00%
-
Merck & Co Inc
00%
-
Pfizer Inc
00%
-
Catalent Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
10175.5
Ticker
CTLT.K
ISIN
US1488061029
IPO date
2014-07-31
Availability on Russian exchanges
Yes
Reporting for
2024-02-14
Date fact. publication of reports
2023-12-31
Company Description
Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: